| Ansøgningsnr. og dato | 20713873.6 (espacenet) (Federated) (European Patent Register), 20200323 | | Patent/reg.nr. og dato | DK/EP 3946464, 20220831 | | Tilgængelighedsdato | 20220209 | | Prioritetsnr. og dato | US 201962826393 P, 20190329, US 202062964177 P, 20200122 | | EP publ. nr. og dato |
EP 3946464 20220209 | | Løbedag | | | Ansøger/indehaver | MedImmune Limited, Milstein Building
Granta Park
Cambridge
Cambridgeshire CB21 6GH, GB | | Ansøgers ref. nr. | 1639522 | | Opfinder | MASTERSON, Luke, C/O MedImmune Limited
Milstein Building, Granta Park
Cambridge Cambridgeshire CB21 6GH, GB,
HOWARD, Philip, Wilson, c/o MedImmune Limited Milstein Building, Granta
Park
Cambridge Cambridgeshire CB21 6GH, GB,
DICKINSON, Niall, c/o MedImmune Limited Milstein Building, Granta
Park
Cambridge Cambridgeshire CB21 6GH, GB,
CAILLEAU, Thais, c/o MedImmune Limited Milstein Building, Granta
Park
Cambridge Cambridgeshire CB21 6GH, GB,
GOUNDRY, William, c/o AstraZeneca 1 Francis Crick Avenue, Cambridge
Biomedical Campus
Cambridge Cambridgeshire CB2 0AA, GB | | Fuldmægtig | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Interessent på tilknyttet sag | | | IPC-Klasse | A61K 47/68 (2017.01) , A61P 35/00 (2006.01) , C07D 491/22 (2006.01) , C07K 5/06 (2006.01) , C07K 5/08 (2006.01) , C07K 5/10 (2006.01) | | Titel/benævnelse | FORBINDELSER OG KONJUGATER DERAF | | Internationalt ansøgningsnr. | EP2020057984 | | Internationalt publ. nr. | WO2020200880 | | Relateret sag (certifikat) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
